SAN DIEGO -- A peripheral perfusion–targeted strategy was not superior to lactate level–targeted resuscitation in lowering mortality for septic shock patients, the ANDROMEDA-SHOCK trial found. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results